Join us for our free, online Q&A’s to hear the latest in breast cancer research and related topics.

Ask the Experts

Hear from some of the world’s leading breast cancer researchers through our free, online, and live Q&A events. The Q&As are aimed at keeping people informed about breast cancer research, clinical trials, and important associated topics, and they enable everyone to watch the events at a time and location that is convenient to them. You will be able to ask our researchers your breast cancer questions on key topics and keep up to date on the latest in breast cancer research. 

Our next online Q&A event will be held on Monday 24 October from 5-6:30pm (AEDT), on the topic of Breast Cancer and Genetics.

Approximately 5-10% of breast cancer cases are thought to be hereditary, where a gene mutation has been passed on directly from a parent. Typically, these women are diagnosed with breast cancer at a young age and may have a more aggressive form of the disease.

In our latest online Q&A moderated by Author and Journalist Annabel Crabb, we will be asking leading researchers your questions about genetics and how it relates to breast cancer. The panel will be discussing current research to improve treatments and to prevent breast cancer and recurrence, who should receive genetic testing and what does this process involve, breast cancer risk factors and family history, and what support is available.

For more information or to register, click here.


Stay Up-To-Date with Past Q&A’s



The definition of ‘young women’ in the breast cancer sense, refers to women who are pre-menopausal or 40 years and younger. Approximately 7% of breast cancers diagnosed in Australia are women in this age group, which equates to approximately 1,000 women each year – 79 of these women are estimated to die from the disease. Breast cancer is the most commonly diagnosed cancer in women. But for those aged 20-39 years in Australia, it is also the most common cause of cancer death.

Some of the challenges facing young women diagnosed with breast cancer may include premature menopause, fertility and sexuality issues, and the impact of breast cancer on caring for young children, education and careers. As a result, young women may experience higher levels of medical and psychosocial distress following a diagnosis.

In this Q&A event, moderated by author and journalist Annabel Crabb, we discussed research and clinical trials to improve treatments and prevention strategies, the psychological impact of breast cancer, treating breast cancer with a multidisciplinary team and support for young women.

Moderated by author and journalist Annabel Crabb, watch Professor Ann Partridge, Ms Laura McCambridge, Ms Leslie Gilham, Associate Professor Lesley Stafford, Associate Professor Nicholas Wilcken, and Dr Holly Keane discuss this important topic.


The fear of breast cancer coming back is one of the most common issues faced by people diagnosed with breast cancer. Fortunately, Australia and New Zealand have some of the best survival rates of breast cancer in the world. In Australia, the five-year survival rate is 91% and its 88% in New Zealand. But despite recurrences usually occurring within five years after the initial treatment, the fear that cancer may return at any time in life is a very normal and common worry for most people.

In this Q&A event, moderated by TV presenter Annabel Crabb, we discussed the latest in research and clinical trials, personal experiences of breast cancer, living with the fear of recurrence and how to manage that fear, as well as what help is available.

Moderated by TV presenter Annabel Crabb, watch Professor Sherene Loi, Professor Prue Francis, Ms Leslie Gilham and Associate Professor Lesley Stafford discuss this important topic.


The experience of being diagnosed with metastatic breast cancer can affect people in different ways and this may include managing different symptoms of this disease and treatments, living with metastatic breast cancer, and how patients and their families cope with an uncertain future.

In this Q&A event, moderated by TV presenter Annabel Crabb, we discussed the latest in research for metastatic breast cancer with leading experts, as well as the psychological impacts of this disease and participating in clinical trials.

Moderated by TV presenter Annabel Crabb, watch Professor Sarah-Jane Dawson, Dr Shom Goel and Associate Professor Lisa Beatty, discuss this important topic.


A breast cancer diagnosis is devastating and can impact all aspects of a person’s life. One aspect that is not often discussed in public, is the impact that a diagnosis and the subsequent treatment has on a person’s sex life.

From psychological impacts such as body image issues, to decreased libido, menopause and fertility issues, breast cancer can affect women in the most intimate ways. In addition to these topics, the Q&A will also discuss examples of research which aims to improve the quality of life of women who have been diagnosed with breast cancer.

Moderated by TV presenter Annabel Crabb, watch Professor Fran Boyle AM, Professor Kate White, Dr Belinda Kiely and Ms Rebecca Angus, discuss this important topic.


Ms Leslie Gilham

CAP chair and clinical trial participant Ms Leslie Gilham talks about participating in a breast cancer clinical trial.

Professor Christobel Saunders

BCT Board director and breast surgeon Professor Christobel Saunders explains what a clinical trial is and the Breast MRI Evaluation Study.

Professor Sarah-Jane Dawson

BCT researcher Professor Sarah-Jane Dawson explains the link between discoveries in the lab and new treatments for patients.


Associate Professor Prue Francis

Associate Professor Prue Francis provides a 2021 BCT clinical trials research update.

Associate Professor Nicholas Wilcken

BCT board director and researcher Associate Professor Nicholas Wilcken runs through the most common risk factors associated with breast cancer.

Professor Erica James

Professor Erica James explains the best way to start or continue exercising during treatment, and what services are available to you after a diagnosis.

Professor Geoffrey Lindeman

Professor Geoffrey Lindeman explains how breast cancer can be prevented in some people and explains the BCT BRCA-P clinical trial.